Vogenx, Inc.
VOGX
$14.93
$0.845.93%
NASDAQ
Corporate Info
Website
Phone Number
919 659 5677
Address
3901 Barrett Drive
Suite 300
Raleigh, NC 27609
Suite 300
Raleigh, NC 27609
Country
United States
Year Founded
2021
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
5
Business Description
Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis. Its products include drugs, such as Mizagliflozin and VGX-2857. It also offers VGX-001, a human monoclonal antibody for the treatment of type 1 diabetes (T1D). It caters to healthcare providers, physicians and third-party payors in the United States. The company was incorporated in 2021 and is based in Raleigh, North Carolina.